Therapy Slows ALS Progression
Studies of a therapy designed to treat amyotrophic lateral sclerosis (ALS), also called Lou Gehrig’s Disease, suggest that the treatment dramatically slows onset and progression of the deadly disorder...
View ArticleNational Heart Centre Singapore discovers patient-specific cure for dangerous...
Public release date: 17-Sep-2013 [ | E-mail | Share ] Contact: Jessica Koh jessica.koh.l.c@nhcs.com.sg 65-643-67924 SingHealth The National Heart Centre Singapore (NHCS) research team has successfully...
View Article"Weeding the Garden" with Radiation Allows ALK+ Lung Cancer Patients to...
Contact Information Available for logged-in reporters only Newswise A University of Colorado Cancer Center study published today in the International Journal of Radiation Oncology Biology and Physics...
View ArticleIn Non-clinical Cancer Studies Senescos Therapeutic Candidate, SNS01-T, Works...
The synergy demonstrated between SNS01-T and current standard-of-care drugs further emphasizes the therapeutic potential of SNS01-T. We are excited by these results since there may be utility for...
View ArticleTodays Top Biotech Stories: Myriad Genetics, Bayer, Amgen, and Synta
Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case they’re material to our investing thesis. Let’s take a closer...
View ArticleBlocking DNA repair mechanisms could improve radiation therapy for deadly...
UT Southwestern Medical Center researchers have demonstrated in both cancer cell lines and in mice that blocking critical DNA repair mechanisms could improve the effectiveness of radiation therapy for...
View ArticleParkinson's drug shows promise in preventing breast cancer
Women with mutations in the BRCA1 gene are at high risk for breast and ovarian cancer, and there are currently no drugs proven to reduce their cancer risk. Now, early research suggests that existing...
View ArticleChanTest Launches new Heart-in-a-Dish Cardiac Safety Assessment Tool
Cleveland, Ohio (PRWEB) May 08, 2014 ChanTest announces a new Heart-in-a-Dish in vitro cardiac safety assessment tool to support this critical component of the drug development process for...
View ArticleCombination Therapy a Potential Strategy for Treating Niemann Pick Disease
Contact Information Available for logged-in reporters only Newswise CAMBRIDGE, Mass. (May 15, 2014) By studying nerve and liver cells grown from patient-derived induced pluripotent stem cells (iPSCs),...
View ArticleCatherine M. Bollard, MBCHB, MD, of Childrens National Performs Its First...
Washington, DC (PRWEB) May 28, 2014 Catherine M. Bollard, MBChB, MD, director of Childrens National Health Systems Program for Cell Enhancement and Technologies for Immunotherapy (CETI), and her team...
View ArticleNew Drug-Based Approach to Regenerative Medicine for Heart Failure
Dr. Mark Penn, founder and CMO of Juventas Therapeutics While the optimal treatment for heart failure was provided to a group of patients, they were still having symptoms. However when a new drug...
View ArticleExperiment at Fred Hutch raises hopes in battling brain tumors
A gene-therapy experiment at Fred Hutchinson Cancer Research Center only involved a handful of brain-tumor patients, and on average, extended their lives by months, not years. Even so, it was the...
View ArticleGene-Silencing Drugs Finally Show Promise
The disease starts with a feeling of increased clumsiness. Spilling a cup of coffee. Stumbling on the stairs. Having accidents that are easy to dismisseveryone trips now and then. But it inevitably...
View ArticleGold nanoparticles linked to single-stranded DNA create a simple but...
11 hours ago Before (top) and after (bottom) images of gold nanoprobe tests. In DNA samples containing no genetic variations, the pink solution became colorless within 10 minutes. Credit: A*STAR...
View ArticleUSC researchers discover dual purpose of cancer drug in regulating expression...
PUBLIC RELEASE DATE: 25-Sep-2014 Contact: Leslie Ridgeway lridgewa@usc.edu 323-442-2823 University of Southern California – Health Sciences LOS ANGELES Keck Medicine of USC scientists have discovered...
View ArticleImpotence Drug Might Counter Common Gene Mutation in Type 2 Diabetes: Study
By Steven Reinberg HealthDay Reporter THURSDAY, Oct. 9, 2014 (HealthDay News) — In a small study, Swedish researchers found that the impotence drug yohimbine might help people with type 2 diabetes who...
View ArticleGene therapy | Cancer Research UK
Researchers are looking at different ways of using gene therapy, including Some types of gene therapy aim to boost the body’s natural ability to attack cancer cells. Our immune system has cells that...
View ArticleStudy may explain why targeted drug doesn't benefit patients with early-stage...
PUBLIC RELEASE DATE: 27-Oct-2014 Contact: Eileen Scahill Eileen.Scahill@osumc.edu 614-293-3737 Ohio State University Wexner Medical Center COLUMBUS, Ohio The drug erlotinib is highly effective in...
View ArticleDirect generation of neural stem cells could enable transplantation therapy
2 hours ago by Nicole Giese Rura Induced neural stem cells (iNSCs) created from adult cells hold promise for therapeutic transplantation, but their potential in this capacity has been limited by failed...
View ArticleSaving Eliza: Family raising money for Sanfilippo Syndrome drug $530K away...
When Glenn ONeill and his wife, Cara, learned about a gene therapy treatment that could save their daughters life, they started a foundation and set off to raise the $2.3 million it would take to fund...
View ArticleFDA approves new ovarian cancer drug
Opening a new chapter in the use of genomic science to fight cancer, the Food & Drug Administration on Friday approved olaparib, a medication for advanced ovarian cancer associated with a...
View ArticleInherited Gene Variations Tied to Treatment-Related Hearing Loss in Cancer...
Contact Information Available for logged-in reporters only Inherited gene variations tied to treatment-related hearing loss in cancer patients St. Jude Childrens Research Hospital scientists have...
View ArticleConclusive link between genetics, clinical response to warfarin uncovered
In a study published in The Lancet on March 10, researchers from Brigham and Women’s Hospital (BWH) report that patients with a genetic sensitivity to warfarin — the most widely used anticoagulant for...
View ArticleNew therapy could help slow down progression of Lou Gehrig's disease
Washington, Sept. 10 (ANI): Researchers have developed a therapy that could dramatically slow the onset and progression of the Lou Gehrig’s disease. The researchers, led by teams from The Research...
View ArticleNew blood cancer drug reaches cells hiding in bone marrow …
SAN DIEGO, July 28 (UPI) — A new drug aimed at dormant cancer stem cells that hide in the hypoxic zones of bone marrow, where most drugs can’t reach, is currently entering 5 Phase II clinical trials...
View Article
